ETAMSYLATE & TRANEXAMIC ACID
|PACKING TYPE||ALU ALU|
Antifibrinolytic hemostatic used in severe hemorrhage.
Oral LD<sub>50</sub> in mice is >10 gm/kg. Symptoms of overdosage may be nausea, vomiting, orthostatic symptoms and/or hypotension.
For use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. It can also be used for excessive bleeding in menstruation, surgery, or trauma cases.